BR 16A

Drug Profile

BR 16A

Alternative Names: Mentat

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Punjab University-Chandigarh
  • Class Antiepileptic drugs; Anxiolytics; Neuroprotectants; Nootropics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Anxiety disorders; Cognition disorders; Seizures; Sleep disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Sleep-disorders in India (PO)
  • 17 Feb 2004 Preclinical trials for Sleep disorders in India (PO)
  • 17 Feb 2004 Data presented at the International Congress of Biological Psychiatry (ICBP-2004) have been added to the Anxiety Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top